The effect of atypical arterial vascularization of the liver on computed tomography signs of hemangiomas

Introduction. The article describes the role of computed tomography in the diagnosis of hemangiomas in various types of hepatic arterial circulation. Aim. To determine the features of contrast enhancement of hemangiomas in multislice computed tomography with multiphase contrast enhancement in patients with abnormalities of the arterial supplement of the liver. Materials and methods. The results of 60 computed tomographic angiographies of patients with hemangiomas of various sizes (mean age of patients 59.2±12.3 years, the study included 34 (57 %) men, 26 (43 %) women) were analyzed. Results. The most common anatomical variants of the vasculature, concomitant anomalies of the arterial supply of other abdominal organs, as well as features of contrast enhancement of hemangiomas depending on their size are described. The analysis of vascular architectonics revealed that the first type of arterial supply according to Mitchels (p <0.05) ) is prevailed, however, 3 (3.3 %), 5 (3.3 %), 6 (6.6 %) types were also determined. Thus, a correlation analysis using Fisher’s exact test was not detected a significant correlation between the presence of hemangiomas in the liver parenchyma and the presence of aberrant (r=0.11, p=0.36) or replacement arterial vessels (r=0.14, p=0.35). At the same time, when visually assessing the contrast enhancement of hemangiomas in different phases of contrast enhancement, both in the presence of aberrant and replacing vessels and without them, the main radiation patterns of changing hemangiomas density remained unchanged. Conclusion. Based on the obtained data on the liver arterial system, the absence of a significant correlation between the type of arterial blood supply, the presence of an additional or replacement vessel, and the type of contrast enhancement of hemangiomas during multiphase computed tomography of the abdominal organs was demonstrated.

1. Кармазановский Г.Г., Шантаревич М.Ю. Обзор международных клинических рекомендаций и данных клинических исследований по диагностике гепатоцеллюлярного рака за 2014–2020 годы. Анналы хир. гепатол. 2021;26(1)12–24. [Karmazanovsky G.G., Shantarevich M.Yu. Review of international clinical recommendations and clinical research data on the diagnosis of hepatocellular cancer for 2014-2020. Ann. surg. Hepatol. 2021;26(1):12-24. (In Russ.)]. DOI: 10.16931/1995-5464.2021112-24.

2. Toro A., Mahfouz A.E., Ardiri A., Malaguarnera M., Malaguarnera G., Loria F., Bertino G., Di Carlo I. What is changing in indications and treatment of hepatic hemangiomas: A review. Ann. Hepatol. 2014;13:327–339.

3. ISSVA Classification of Vascular Anomalies 2018 International Society for the Study of Vascular Anomalies Available at issva.org/classification. Accessed 28.01.2020.

4. Leon M., Chavez L., Surani S. Hepatic hemangioma: What internists need to know. World J. Gastroenterol. 2020; 26(1):11–20. DOI: 10.3748/wjg.v26.i1.11.

5. Yamashita Y., Ogata I., Urata J., Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology. 1997;203:121–125. DOI: 10.1148/radiology.203.1.9122378.

6. Madrazo B.L. Using imaging studies to differentiate among benign liver tumors. Gastroenterol. Hepatol. (N Y). 2011;6(7):423-427.

7. Oto A., Kulkarni K., Nishikawa R. et al. Contrast enhancement of hepatic hemangiomas on multiphase MDCT: Can we diagnose hepatic hemangiomas by comparing enhancement with blood pool? AJR Amer J Roentgenol. 2010;195(2):381– 386. DOI: 10.2214/AJR.09.3324.

8. Vilgrain V., Boulos L., Vullierme M.P. et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20(2)379–397. DOI: 10.1148/ radiographics.20.2.g00mc01379.

9. Балахнин П.В., Таразов П.Г. Классификация вариантов артериального кровоснабжения печени для рентгеноэндоваскулярных вмешательств: анализ результатов 3756 ангиографий. Анналы хир. гепатол. 2014;19(2):24– 41. [Balakhnin P.V., Tarazov P.G. Anatomical classification of arterial blood supply to the liver for radio endovascular procedures: analysis of 3756 hepatic angiographies. Ann. surg. Hepatol. 2014;19(2):24–41. (In Russ.)].

10. Якшиева Г. М. и др. Новый вариант артериальной анатомии гепато-панкреатобилиарной зоны. Эндоваскулярная хир. 2020;7(4). [Yakshieva G. M. et al. A new variant of the arterial anatomy of the hepato-pancreatobiliary zone. Endovas. Surg. 2020;7(4). (In Russ.)].

11. Балахнин П. В., Таразов П. Г., Поликарпов А. А. и др. Варианты артериальной анатомии печени по данным 1511 ангиографий. Анналы хир. гепатол. 2004;9(2):1–10. [Balakhnin P.V., Tarazov P.G., Polikarpov A.A. et al. The Angiographic Evaluated of the Hepatic Arterial Anatomy Variations in 1511 Patients. Ann. surg. Hepatol. 2004;9(2):1– 10. (In Russ.)].

12. Базаев А.В., Кокобелян А.Р., Акуленко Д.С и др. Критерии выбора оптимального метода лечения гемангиом печени. Современные технологии в медицине. 2020; 12(1). [Bazaev A.V., Kokobelyan A.R., Akulenko D.S. et al. Criteria for choosing the optimal method of treatment of liver hemangiomas. Modern technol. Med. 2020;12(1)(In Russ.)]. DOI: 10.17691/stm2020.12.1.13.

13. Grazioli L., Ambrosini R., Frittoli B. et al. Primary benign liver lesions Europ. J. Radiol. 2017;95:378–398. DOI: 10.1016/j.ejrad.2017.08.028.

14. Patacsil S.J., Noor M., Leyva A.A. et al. Review of Benign Hepatic Tumors and Their Imaging Characteristics. Cureus. 2020;12(1):1–9. DOI: 10.7759/cureus.6813.

15. Лебедев Д.П. и др. Оценка влияния эндоваскулярного доступа на эффективность и безопасность химиоэмболизации артерий печени при нерезектабельных метастазах в печень. Клин. практика. 2019;10(4):5–15. [Lebedev D.P. et al. Evaluation of the effect of endovascular access on the efficacy and safety of chemoembolization of liver arteries in unresectable liver metastases. Clin. Practice. 2019;10(4):5–15 (In Russ.)]. DOI: 10.17816/clinpract17941.